Khwaja Abdul Hamied and the incredible story of Cipla

In the 1920s, an affluent father wanted his son to become a barrister. But the son chose to pursue chemistry instead. Learn the incredible story of Khwaja Hamied, the founder of Cipla.

During the 1920s, an affluent father wanted his son to become a barrister, a profession accepted by privileged Indian families in that era. But the son had no interest in studying law. He mounted on his ship of United Kingdom and waved his father goodbye. Halfway across the ocean he switched his ship and landed in Germany. Germany at that time was booming with chemicals and chemists. The son got his education and returned back in India with a degree in chemistry. 

This was none other than Khwaja Abdul Hamied, the founder of Cipla. Coming from Germany with a Jewish wife and chemistry degree, he opened the Chemical, Industrial and Pharmaceutical Laboratories in 1935. This was the predecessor of Cipla which got renamed in 1984. Khwaja Abdul Hamied was a follower of Mahatma Gandhi and Jawaharlal Nehru. He opened his company with the aim to help the poorest of Indians get access to affordable and quality medicines. 

Even after the partition, when Mohammad Ali Jinnah asked a fellow Muslim, Khwaja Hamied, to join Pakistan, Hamied refused. He was a follower of Gandhi and his sympathies were with India. Even while handing over his company to his son, Khwaja Hamied said, “Unlike other pharmaceutical companies around the world, we are not here to make profits but to bring relief and healthcare to the poor who may otherwise have to die for want of quality drugs.”

Yusuf Hamied was the son of Cipla’s founder who had studied chemistry at Cambridge University. He joined the company as an R&D officer. Under him, the bulk of the company’s drugs received USA’s FDA approval. In the 1990s, Cipla made a major breakthrough, they combined three anti-retroviral drugs into one dose. In 1991, the company made a breakthrough in cancer chemotherapy in partnership with the Indian Institute of Chemical Technology. 

Later in 1995, they made the world’s first oral iron chelator named Deferiprone. They also created the world’s first dry powder inhaler device named Rothaler. In 2001, Cipla came up with HIV medicines at a cost of $350 per year per patient, when the whole world was charging $1200 approximately for the same. 

At end of FY19, Cipla had a turnover of Rs 16,792 crores. They were the market leader with a share of 21.8% in respiratory therapy. Cipla has outranked every company to become the best provider of respiratory therapy. With its forte in respiratory disease solutions, Cipla plans to capitalise on the limited competition in the global respiratory medicines and therapies market. They plan to grow products that can deliver drugs into the body through the respiratory tract.

In short, the 86 year old company still has a long journey ahead.

Tags : #KhwajaHamied #Cipla #YusufHamied #IndianPharmaceuticalCompany #globalleader #pharmacy #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024